For countless individuals in the UK, a seemingly benign trait – extreme flexibility – masks a complex and debilitating condition, Hypermobility Spectrum Disorder (HSD), leading to an average diagnostic delay of nearly two decades. This profound gap in recognition leaves sufferers navigating a labyrinth of unexplained symptoms, often dismissed or misdiagnosed, highlighting a critical failure in medical understanding and support.
This pervasive delay in diagnosing Hypermobility Spectrum Disorder (HSD) and its more severe counterpart, hypermobile Ehlers-Danlos Syndrome (hEDS), underscores a significant public health challenge in the UK. What many once considered a party trick or a desirable athletic attribute is now understood as a connective tissue disorder impacting multiple bodily systems, causing chronic pain, fatigue, and a host of other debilitating symptoms. The stories of Vivienne Duval, diagnosed at 58, and Ella Kipling, the author, diagnosed at 24, are poignant examples of a widespread issue where individuals endure years, even decades, of suffering before finding an explanation for their myriad health problems. This article delves into the nature of these conditions, the systemic failures in diagnosis and management, and the profound daily impact on those affected, advocating for urgent recognition and improved clinical pathways.
Vivienne Duval’s journey is a stark illustration of the diagnostic odyssey faced by many with Hypermobility Spectrum Disorder (HSD). For decades, her exceptional flexibility, which allowed her to effortlessly master every yoga pose, was viewed as a personal asset rather than a red flag. Yet, beneath this seemingly advantageous trait lay a constellation of puzzling health issues: persistent digestive problems, crushing fatigue, and chronic pain that defied easy explanation. It wasn’t until the age of 58, when a social media video vividly outlining the symptoms of HSD caught her attention, that the disparate pieces of her health puzzle finally coalesced. "I saw myself in everything they were saying," she recounts, a "light bulb switching on" that illuminated years of unexplained suffering. Armed with newfound information, Vivienne sought medical confirmation, her intuition proving correct: she had hypermobile joints. "I had all these separate things, but no one had ever put them all together. Now it’s blindingly obvious," she reflects, her words echoing the frustration and relief common among those finally diagnosed.
Hypermobility Spectrum Disorders (HSD) and hypermobile Ehlers-Danlos Syndrome (hEDS) are a group of inherited connective tissue disorders characterized by joint hypermobility, where joints extend beyond their normal range of motion. The root cause lies in faulty collagen, the primary protein in connective tissues, which acts as the body’s structural glue. When collagen is lax or "stretchy," it fails to provide adequate support to joints, ligaments, and tendons. This laxity forces muscles to work overtime to maintain joint stability, leading to chronic muscle strain, pain, and profound fatigue. Beyond the musculoskeletal system, the widespread nature of connective tissue means that HSD and hEDS can manifest in a bewildering array of systemic symptoms. These include gastrointestinal issues due to stretchier connective tissue in the digestive tract, autonomic dysfunction leading to symptoms like fainting or dizziness upon standing (orthostatic intolerance), poor wound healing, easy bruising, bladder and bowel problems, and even neurological manifestations such as chronic headaches and "brain fog." Emerging research has also established significant links between HSD and neurodiversity, including conditions like autism and ADHD, further complicating the clinical picture and expanding the diagnostic criteria. Hypermobile Ehlers-Danlos Syndrome (hEDS) represents the most common and often most severe form of Ehlers-Danlos Syndromes, diagnosed through a combination of hypermobility assessment and a detailed evaluation of systemic connective tissue involvement, including musculoskeletal problems like frequent dislocations or subluxations, and other characteristic signs such as stretchy skin or abnormal scarring.
The scale of this diagnostic crisis is profound. Recent research from the University of Edinburgh indicates that hypermobility disorders may affect hundreds of thousands of people across the UK, yet a staggering number remain undiagnosed. The study’s findings are particularly alarming, revealing that patients with hEDS and HSD in the UK endure an average diagnostic delay of 19 to 21.7 years. This protracted wait means individuals spend nearly two decades grappling with symptoms that profoundly impact their quality of life, education, career, and mental well-being, all without a coherent medical explanation or appropriate management strategy.
Several systemic factors contribute to this pervasive diagnostic delay. A major hurdle is the absence of a dedicated, standalone clinical guideline from the National Institute for Health and Care Excellence (NICE) specifically for the diagnosis of HSD and hEDS. This lack of clear, nationally recognized guidance leaves healthcare professionals without a standardized framework for identifying and managing these complex conditions. Dr. Jessica Eccles, a leading researcher specializing in brain-body interactions and hypermobility, highlights the resulting "postcode lottery" for diagnosis, where access to assessment and expert knowledge is heavily dependent on geographical location and the availability of specialized clinics or informed clinicians. Compounding this issue is a discernible gender bias; Dr. Eccles notes that HSD and hEDS appear to disproportionately affect women, yet "women’s health is not necessarily as well-researched as problems affecting men." This historical underrepresentation in medical research likely contributes to the delayed recognition and understanding of conditions more prevalent in women. The Edinburgh research further underscores the inadequacy of current primary care responses, finding that less than a third of diagnosed individuals reported their GP initiating management for the disorder, and a dismal 13% had access to a "knowledgeable clinician" who truly understood their condition.
This systemic neglect leaves many patients feeling abandoned and without recourse. Dr. Stephanie Barrett, a consultant physician and rheumatologist, frequently encounters patients in her clinic who are unable to work due to the debilitating "severe brain fog" linked to their hypermobility. She laments the recurring narrative of individuals struggling to navigate a healthcare system that fails to acknowledge or adequately address their condition. Vivienne Duval’s experience resonates deeply with this sentiment: "I need to be able to help myself and I don’t know where to go. I’m finding out about this condition on social media." Her mix of frustration and profound relief upon receiving a diagnosis, however belated, is a common reaction among those who have endured years of medical gaslighting or misdiagnosis.
As the author, Ella Kipling, I can intimately relate to Vivienne’s journey and the complex emotions that accompany a diagnosis of HSD. Fortunate to have been diagnosed at 24, significantly earlier than many sufferers, I still spent years grappling with a bewildering array of health issues. Like Vivienne, I experienced persistent joint pain, chronic fatigue that no amount of sleep could alleviate, and frequent digestive problems. Growing up, I simply assumed I was unlucky, burdened with myriad unrelated ailments. The revelation that these seemingly disparate symptoms were all connected to my "bendy joints" was transformative. Conversations with my consultant brought clarity to experiences I had long normalized: my frequent clumsiness was not merely a personal quirk but a manifestation of HSD; waking up perpetually exhausted was not the universal human experience; and the intense pain I felt from simply standing in a queue or on a train was not something most people endured. This understanding, though validating, also underscores the profound isolation and "imposter syndrome" that can accompany an invisible illness.
Luke Grindlay, 23, offers another perspective on the daily impact of HSD. Diagnosed in primary school after teachers observed his difficulties with fine motor skills, such as using pens and cutlery, Luke’s experience highlights how early symptoms can be overlooked or misinterpreted. Despite an early diagnosis, he admits to not actively seeking treatment, a decision he attributes to a form of "imposter syndrome" fueled by the scarcity of accessible information on HSD. "If you go online to research this, there’s nothing there… I’m going through a lot of pain, but because I can’t find anything about it, it’s almost like I’m making too much of it," he explains. This sentiment perfectly encapsulates the psychological burden of a poorly understood condition – the self-doubt, the feeling of exaggerating one’s pain, and the reluctance to articulate symptoms that others might dismiss. The unpredictable nature of HSD’s impact, which I also experience, further complicates matters; some days I can engage in strenuous activity with minimal discomfort, while others, a simple shopping trip can be utterly debilitating. Luke, who works in golf, finds the prolonged standing and waiting often required by his role incredibly painful. Yet, communicating this to colleagues or employers is challenging because "not many people know about the condition." He notes that the impacts are hitting "harder" as he ages, a common progression for many with hypermobility. Vivienne’s social life and work have similarly been reshaped by her condition. Once a mobile massage therapist, the inability to stand for extended periods and the overwhelming fatigue forced her to change careers. She now works as a massage therapist for people living with dementia, a role that is less physically demanding, demonstrating the significant adaptive measures many sufferers must undertake.
Dr. Eccles emphasizes that HSD symptoms can often worsen, or even become apparent, following a significant physiological stressor. These triggers can include pivotal life stages such as puberty or menopause, which introduce hormonal shifts that can impact connective tissue integrity. Intriguingly, some emerging research also suggests a potential link between the onset or exacerbation of HSD symptoms and infections like COVID-19, indicating that external environmental stressors can play a crucial role in activating or intensifying the condition. This means an individual could navigate much of their life with only mild or unacknowledged hypermobility, only for an "external environmental stressor" to dramatically worsen their symptoms, transforming a manageable flexibility into a debilitating disorder.
While there is no "single magic bullet" cure for HSD, effective management strategies exist. Physiotherapy is widely recognized as a cornerstone of treatment. Dr. Barrett explains that carefully tailored physiotherapy programs are designed to "tone up and strengthen the key muscles which hold the skeleton together," thereby compensating for lax ligaments and improving joint stability. Gentle, low-impact exercises like swimming are also frequently recommended, as they provide joint support and build muscle strength without putting excessive strain on hypermobile joints. However, Dr. Barrett expresses frustration with the prevailing tendency to simply advise sufferers to "just do a bit of physio" and carry on with their lives. This oversimplified approach often fails to address the systemic nature and profound daily impact of HSD and hEDS. Ultimately, both Dr. Eccles and Dr. Barrett concur that a far more comprehensive and collaborative approach is urgently needed. This includes enhanced research, improved education for medical professionals, and greater public awareness. Dr. Barrett concludes, "It takes people working together and sharing ideas, and for the government to recognise this, to tackle this." Without such concerted efforts, countless individuals will continue to suffer in silence, their years of pain and confusion extending into decades, waiting for the medical community to catch up to their reality.
